Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-23T06:27:13.632Z Has data issue: false hasContentIssue false

Case 16: Second-generation antipsychotics/mixed dopamine–serotonin receptor agonists (SGAs), side effects, and the autism spectrum: SGA-related side effects in a boy with autism spectrum disorder (ASD)

Published online by Cambridge University Press:  09 February 2024

Jeffrey R. Strawn  and
Stephen M. Stahl
Jeffrey R. Strawn
Affiliation:
University of Cincinnati, Ohio
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

Which of the following is associated with the greatest incidence of hyperprolactinemia?

Type
Chapter
Information
Case Studies: Stahl's Essential Psychopharmacology
Children and Adolescents
 , pp. 259 - 278
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aman, M., Rettiganti, M., Nagaraja, H. N., et al. Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial. J Child Adolesc Psychopharmacol 2015; 25(6): 482–93. https://doi.org/10.1089/cap.2015.0005Google Scholar
Dominick, K. C., Wink, L. K., Pedapati, E. V., et al. Risperidone treatment for irritability in fragile X syndrome. J Child Adolesc Psychopharmacol 2018, 28(4): 274–78. https://doi.org/10.1089/cap.2017.0057Google Scholar
Erickson, C. A., Stigler, K. A., Wink, L. K., et al. A prospective open-label study of aripiprazole in fragile X syndrome. Psychopharmacology 2011; 216(1): 85–90. https://doi.org/10.1007/s00213-011-2194-7Google Scholar
Gotham, K., Pickles, A., Lord, C. Standardizing ADOS scores for a measure of severity in autism spectrum disorders. J Autism Develop Disord 2009; 39(5): 693–705. https://doi.org/10.1007/s10803-008-0674-3Google Scholar
Gotham, K., Risi, S., Pickles, A., Lord, C. The autism diagnostic observation schedule: revised algorithms for improved diagnostic validity. J Autism Develop Disord 2007; 37(4): 613–27. https://doi.org/10.1007/s10803-006-0280-1Google Scholar
Hersh, J. H., Saul, R. A. Health supervision for children with fragile X syndrome (clinical report). In Pediatric Clinical Practice Guidelines & Policies. Itasca, IL: American Academy of Pediatrics, 2021. https://doi.org/10.1542/9781581108224-health8_sub01Google Scholar
Kloosterboer, S. M., de Winter, B. C. M., Reichart, C. G., et al. Risperidone plasma concentrations are associated with side effects and effectiveness in children and adolescents with autism spectrum disorder. Br J Clin Pharmacol 2021; 87(3): 1069–81. https://doi.org/10.1111/bcp.14465Google Scholar
Koch, M. T., Carlson, H. E., Kazimi, M. M., Correll, C. U. Antipsychotic-related prolactin levels and sexual dysfunction in mentally ill youth: a 3-month cohort study. J Am Acad Child Adolesc Psychiatry 2023; 15: S08908567(23)00125-9. doi: 10.1016/j.jaac.2023.03.007. Epub ahead of print. PMID: 36931560.Google Scholar
McCracken, J. T., McGough, J., Shah, B., et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002; 347(5): 314–21. https://doi.org/10.1056/nejmoa013171Google Scholar
Muhle, R. A., Reed, H. E., Vo, L. C., et al. Clinical diagnostic genetic testing for individuals with developmental disorders. J Am Acad Child Adolesc Psychiatry 2017; 56(11): 910–13. https://doi.org/10.1016/j.jaac.2017.09.418Google Scholar
Savatt, J. M., Myers, S. M. Genetic testing in neurodevelopmental disorders. Front Pediatr 2021; 9. https://doi.org/10.3389/fped.2021.526779Google Scholar
Strawn, J. R., Geracioti, T. D. Editorial: a better perspective on antipsychotic-related hyperprolactinemia in children and adolescents. J Am Acad Child Adolesc Psychiatry 2023: S0890-8567(23)00240-X. doi: 10.1016/j.jaac.2023.05.003. Epub ahead of print. PMID: 37172820.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×